Aadi Bioscience (AADI) stock Forecast for 2021 – 2025

Aadi Bioscience (AADI) stock Forecast for 2022 – 2026

Last update: October 6, 2022 (17:30)

Sector: Healthcare

The share price of Aadi Bioscience, Inc. (AADI) now

What analysts predict: $43.5

52-week high/low: $32.5 / $11

50/200 Day Moving Average: $13.19 / $16.19

This figure corresponds to the average price over the previous 50/200 days. For Aadi Bioscience stocks, the 50-day moving average is the support level today.

For Aadi Bioscience stocks, the 200-day moving average is the resistance level today.

Are you interested in Aadi Bioscience, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aadi Bioscience stock price in 2022, 2023, 2024, 2025, 2026. How much will one Aadi Bioscience share be worth in 2022 - 2026?

When should I take profit in Aadi Bioscience stock? When should I record a loss on Aadi Bioscience stock? What are analysts' forecasts for Aadi Bioscience stock? What is the future of Aadi Bioscience stock?

We forecast Aadi Bioscience stock performance using neural networks based on historical data on Aadi Bioscience stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aadi Bioscience stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aadi Bioscience shares. This happens once a day.



Fresh insight into Aadi Bioscience stock

View all analytics

Aadi Bioscience: Taking mTOR Inhibition To The Next Level

Aadi Bioscience: Taking mTOR Inhibition To The Next Level
September 21, 2022

Summary Shares have lost half their value since reverse merger with Aerpio Pharmaceuticals. Aadi aims to deliver on the broad potential of mTOR inhibition via nab technology to achieve wide … Read more

Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning

Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
November 25, 2021

Summary Aadi Bioscience receives FDA approval of Fyarro for treatment of patients with PEComa. Fyarro (ABI-009) can be expanded upon in two specific gene pathways known as TSC1 and TSC2; … Read more



Historical and forecast chart of Aadi Bioscience stock

The chart below shows the historical price of Aadi Bioscience stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aadi Bioscience stock price can be found in the table below.

Long-term forecasts by years.

Aadi Bioscience daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 08 14.50 14.22 14.95 5.15
Oct 09 14.51 13.98 14.87 6.38
Oct 10 14.13 13.68 14.41 5.32
Oct 11 13.50 13.23 14.04 6.07
Oct 12 14.00 13.54 14.42 6.46
Oct 13 13.70 13.35 14.02 5.03
Oct 14 13.83 13.59 14.14 4.02
Oct 15 13.62 13.46 14.07 4.55
Oct 16 14.16 13.82 14.31 3.59
Oct 17 14.13 13.94 14.45 3.70
Oct 18 13.74 13.23 14.22 7.48
Oct 19 13.69 13.19 13.90 5.35
Oct 20 14.20 13.84 14.67 5.95
Oct 21 13.86 13.59 14.06 3.47
Oct 22 13.98 13.53 14.22 5.06
Oct 23 14.03 13.73 14.34 4.50
Oct 24 14.66 14.31 14.99 4.76
Oct 25 15.35 14.75 15.55 5.41
Oct 26 15.43 14.99 15.91 6.18
Oct 27 15.63 15.13 16.01 5.84
Oct 28 15.88 15.46 16.50 6.73
Oct 29 15.44 14.83 15.96 7.60
Oct 30 16.11 15.48 16.53 6.76
Oct 31 15.94 15.41 16.18 5.02
Nov 01 16.31 15.66 16.89 7.86
Nov 02 16.58 16.08 16.79 4.38
Nov 03 16.89 16.23 17.07 5.15
Nov 04 16.05 15.50 16.42 5.96
Nov 05 16.21 15.93 16.47 3.36
Nov 06 16.59 15.97 16.86 5.56

Aadi Bioscience Daily Price Targets


Aadi Bioscience Stock Forecast 10-08-2022.

Forecast target price for 10-08-2022: $14.50. Positive dynamics for Aadi Bioscience shares will prevail with possible volatility of 4.898%.

Pessimistic target level: 14.22

Optimistic target level: 14.95


Aadi Bioscience Stock Forecast 10-09-2022.

Forecast target price for 10-09-2022: $14.51. Positive dynamics for Aadi Bioscience shares will prevail with possible volatility of 6.000%.

Pessimistic target level: 13.98

Optimistic target level: 14.87


Aadi Bioscience Stock Forecast 10-10-2022.

Forecast target price for 10-10-2022: $14.13. Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 5.051%.

Pessimistic target level: 13.68

Optimistic target level: 14.41


Aadi Bioscience Stock Forecast 10-11-2022.

Forecast target price for 10-11-2022: $13.50. Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 5.721%.

Pessimistic target level: 13.23

Optimistic target level: 14.04


Aadi Bioscience Stock Forecast 10-12-2022.

Forecast target price for 10-12-2022: $14.00. Positive dynamics for Aadi Bioscience shares will prevail with possible volatility of 6.068%.

Pessimistic target level: 13.54

Optimistic target level: 14.42


Aadi Bioscience Stock Forecast 10-13-2022.

Forecast target price for 10-13-2022: $13.70. Negative dynamics for Aadi Bioscience shares will prevail with possible volatility of 4.790%.

Pessimistic target level: 13.35

Optimistic target level: 14.02


AADI (AADI) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Nov. 16.26 14.37 18.27 21.35
Dec. 15.28 14.30 16.93 15.52

Aadi Bioscience forecast for this year


Aadi Bioscience Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $16.2564. Pessimistic: $14.37. Optimistic: $18.27


Aadi Bioscience Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $15.281. Pessimistic: $14.30. Optimistic: $16.93




Aadi Bioscience (AADI) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 16.17 14.13 16.85 16.12
Feb 16.49 14.35 17.74 19.14
Mar 17.35 15.79 18.08 12.67
Apr 17.83 15.98 20.44 21.82
May 19.97 17.10 21.01 18.63
Jun 20.97 18.79 22.69 17.19
Jul 19.88 17.93 21.63 17.10
Aug 22.55 20.16 25.57 21.16
Sep 18.35 16.22 20.70 21.63
Oct 17.58 15.05 20.36 26.08
Nov 20.92 19.16 22.97 16.58
Dec 19.92 18.60 22.19 16.16

Aadi Bioscience (AADI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 22.31 19.94 25.70 22.40
Feb 22.00 19.75 23.67 16.54
Mar 24.28 21.08 26.13 19.33
Apr 25.74 23.73 28.26 16.03
May 29.45 27.21 31.74 14.29
Jun 31.57 27.15 34.53 21.39
Jul 28.79 24.30 30.00 19.00
Aug 26.95 24.20 29.16 17.01
Sep 22.26 20.83 25.33 17.75
Oct 24.04 21.68 25.58 15.23
Nov 27.45 24.10 31.79 24.18
Dec 28.06 26.82 30.75 12.77



Aadi Bioscience (AADI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 26.60 22.66 28.35 20.07
Feb 28.73 24.19 31.43 23.03
Mar 30.79 26.24 32.46 19.17
Apr 30.36 27.81 32.55 14.55
May 26.48 23.67 29.39 19.46
Jun 31.56 29.29 33.33 12.12
Jul 32.82 28.62 37.02 22.70
Aug 37.42 34.12 39.74 14.12
Sep 34.12 32.42 35.83 9.52
Oct 31.12 27.64 34.05 18.83
Nov 29.88 27.61 32.62 15.38
Dec 28.80 24.71 30.24 18.29

Aadi Bioscience (AADI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 33.24 28.58 38.02 24.83
Feb 33.57 31.96 36.59 12.66
Mar 34.24 32.66 36.09 9.49
Apr 35.95 33.00 40.91 19.33
May 34.51 31.06 37.34 16.82
Jun 35.89 31.37 41.21 23.87
Jul 38.34 36.80 41.40 11.11
Aug 38.57 33.24 42.65 22.06
Sep 42.11 40.26 46.83 14.03
Oct 48.09 43.09 52.13 17.34
Nov 46.07 42.76 50.96 16.09
Dec 41.65 38.98 44.23 11.86

Aadi Bioscience information and performance

Aadi Bioscience, Inc, formerly Aerpio Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing precision therapies for genetically defined cancers. It develops therapies for cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. Its lead product, FYARROTM, is an mTOR inhibitor bound to human albumin that has tumor accumulation, mTOR target suppression, and tumor growth inhibition over other mTOR inhibitors in preclinical models2. Its nab platform allows for intratumoral drug accumulation and mTOR target suppression (pS6) at equal doses for FYARROTM vs oral mTOR inhibitors resulting in higher anti-tumor activity in animal models. Its product, FYARROTM, is in phase II registrational trial for nab-sirolimus, ABI-009 in patients with advanced perivascular epithelioid cell tumors (PEComa).

Aadi Bioscience Address

9987 CARVER ROAD, CINCINNATI, OH, US

Market Capitalization: 294 025 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -57 346 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -8.81

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 18.23

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 26.69

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.337

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 21016800

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.